• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Symatese Evolysse Form; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Symatese Evolysse Form; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number EVO-FRM-01
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Bruise/Contusion (1754); Obstruction/Occlusion (2422); Pallor (2468)
Date of Event 08/21/2026
Type of Reportable Event Serious Injury
Event or Problem Description
An hcp reported injecting 0.2 cc of evolysse form into a patient's pyriform aperture using a 25-gauge cannula.When the tissue blanched, the hcp immediately withdrew the cannula, injected two vials of hylenex, applied a warm compress, and massaged the area.The patient subsequently developed bruising and mottling.An md confirmed a vascular occlusion in the left nasolabial fold, which resolved after ultrasound-guided hylenex treatment.
 
Additional Manufacturer Narrative
The product was injected into the patient and is not available for return.The production records for the lot were reviewed, and no deviations were found during production that would relate to the reported event; the device met all specifications.There were no similar complaints received for this lot of product.Based on the reported information, this event is consistent with a vascular occlusion which is a known serious adverse event documented in the labeling.This can occur due to unintended injection into a blood vessel or injection of a large amount of filler near a blood vessel causing compression of the blood vessel.Both occlusion and compression may result in reduced or cessation of blood supply to tissues.Intervention is required to prevent serious and permanent complications.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Evolysse Form
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
Symatese
zi les troques
chapnost, auvergne-rhone-alpes 69630
FR  69630
Manufacturer (Section G)
Symatese
zi les troques
chapnost, auvergne-rhone-alpes 69630
FR   69630
Manufacturer Contact
geraldine bourges
zi les troques
chapnost, auvergne-rhone-alpes 69630
FR   69630
MDR Report Key50803126
Report Number3003672980-2026-00016
Device Sequence Number8596998
Product Code LMH
UDI-Device Identifier03760172161264
UDI-Public(01)03760172161264(17)270531(10)S2252040274
Combination Product (Y/N)Y
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P240022
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Distributor
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 09/17/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberEVO-FRM-01
Device Lot NumberS2252040274
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/21/2026
Initial Report FDA Received Date09/17/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/19/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age56 YR
Patient SexFemale
-
-